Clinical Trial Update: A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated adding serotonin reuptake inhibitors to stimulant therapy in youth with severe mood dysregulation, with results posted after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Attention Deficit and Disruptive Behavior Disorder
• Mental Disorder Diagnosed in Childhood
• Mood Disorder

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Mood Disorder, Mental Disorder Diagnosed in Childhood | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07